ArticleBioinformatics advances2025
Exploring SARS-CoV-2 spike protein mutations through genetic algorithm-driven structural modeling.
Article in Bioinformatics advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Motivation: The rapid evolution of SARS-CoV-2 highlights the importance of computational approaches to explore mutational effects on the viral spike protein. In this work, we present a genetic algorithm (GA) framework applied to the structural optimization of spike protein variants, with a focus on energetic and binding properties rather than direct evolutionary prediction. Results: Our GA-driven pipeline generated spike variants with progressively improved structural stability as indicated by lower discrete optimized protein energy scores across generations. The approach also enabled evaluation of Gibbs free energy and binding affinity for spike-Angiotensin-converting enzyme 2 receptor interactions, revealing candidate conformations with favorable thermodynamic properties. These results demonstrate the algorithm's capacity to refine protein models and explore mutational landscapes in silico, although no validation against naturally emerging variants was performed. This study presents a methodological framework for GA-based structural modeling of SARS-CoV-2 spike mutations. Rather than forecasting specific variants of concern, it demonstrates the feasibility of a computational approach that can be extended and integrated with evolutionary and experimental evidence to strengthen future efforts in variant monitoring and vaccine development. Availability and implementation: All the Python and R scripts are available upon request to the authors.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.